• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALCON RESEARCH, LTD. - IRVINE TECHNOLOGY CENTER CONSTELLATION VISION SYSTEM; UNIT, PHACOFRAGMENTATION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALCON RESEARCH, LTD. - IRVINE TECHNOLOGY CENTER CONSTELLATION VISION SYSTEM; UNIT, PHACOFRAGMENTATION Back to Search Results
Model Number TABLETOP
Device Problems Air Leak (1008); Collapse (1099); Decrease in Pressure (1490)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 11/03/2016
Event Type  malfunction  
Manufacturer Narrative
Investigation including root cause analysis is in progress.A supplemental mdr will be filed as necessary in accordance with 21 cfr 803.56 when additional reportable information becomes available.(b)(4).
 
Event Description
A customer reported that during a procedure, the patient's intraocular pressure (iop) decreased which lead to the globe collapsing.The event occurred during the transition of fluid eye to air (fax).The operating perimeters were as follows: iop 20mmhg, fax 35mmhg.The surgeon was using a vacuum of approximately 150-200mmhg when he noticed the eye collapsing.The vitrectomy cutter was in the off position.The surgeon went back to fluid infusion to inflate the eye.During this stage, fluid flowed into the globe followed by some air bubbles then fluid again, via the infusion line.Once good global pressure, 2mmhg was established, the surgeon proceeded to perform the fax and did so successfully.The case was then completed.There is no known harm to the patient.
 
Manufacturer Narrative
A company clinical analyst reviewed this case and stated the following: ¿the customer reported that during surgery the patient's intraocular pressure (iop) decreased which lead to the globe collapsing.The event occurred during the transition of fluid to air exchange (fax).The operating perimeters were as follows: iop 20mmhg, fax 35mmhg.The surgeon was using a vacuum of approximately 150-200mmhg when he noticed the eye collapsing.The vitrectomy cutter was in the off position.The surgeon went back to fluid infusion to inflate the eye.During this stage, fluid flowed into the globe followed by some air bubbles then fluid again, via the infusion line.Once good global pressure, 2mmhg was established, the surgeon proceeded to perform the fax.The surgery was completed successfully.There is no known harm to the patient.Intraocular surgery has always been recognized to induce substantial intra-ocular pressure (iop) fluctuations, this is true for both anterior (i.E.Cataract surgery) and posterior segment (i.E.Vitrectomy) surgeries.Acute ocular hypotony is common during many intraocular surgeries.Intra-operatively, maintenance of eye pressure is a balance between infusion (irrigation) and extrusion (aspiration) with both parameters actively controlled by the surgeon and with the advent of iop control features, supported by vitrectomy/phaco machines.Hypotony (<5mmhg) is in fact fairly common in eye surgery that most eye surgeons anticipate this to occur during surgery.Surgeons have been trained to recognize and mitigate this by adjustment of the previously mentioned parameters be it manually or through the machine to adapt to what is being performed during surgery.As stated in the system operators manual: ¿the closed loop system that adjusts iop cannot replace the standard of care in judging iop intraoperatively.The surgeon must continue the common practice of informally judging the following: finger palpation on the globe, tactile feedback of the surgical instruments, retinal vessel perfusion/pulsations, and presence of corneal edema.If the surgeon believes the iop is not responding to the system settings and is dangerously high, the surgeon can do one or more of the following as they deem appropriate in this situation (with care to avoid sudden hypotony): close the infusion stopcock, pinch the infusion line, remove the infusion line.¿ no further information was able to be obtained from this customer.With no additional, related information provided, the customers reported event was not able to be confirmed.The system was manufactured on june 20, 2016.A review of the manufacturing records in did not reveal any related non-conformity during manufacturing for this system.Based on qa assessment, the product met specifications at the time of release.The root cause cannot be determined conclusively.(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CONSTELLATION VISION SYSTEM
Type of Device
UNIT, PHACOFRAGMENTATION
Manufacturer (Section D)
ALCON RESEARCH, LTD. - IRVINE TECHNOLOGY CENTER
15800 alton parkway
irvine CA 92618
Manufacturer (Section G)
ALCON RESEARCH, LTD. - IRVINE TECHNOLOGY CENTER
15800 alton parkway
irvine CA 92618
Manufacturer Contact
rita lopez
6201 south freeway
mail stop ab2-6
fort worth, TX 76134
8175514846
MDR Report Key6128888
MDR Text Key61234102
Report Number2028159-2016-05407
Device Sequence Number1
Product Code HQC
Combination Product (y/n)N
Reporter Country CodeNZ
PMA/PMN Number
K101285
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Health Professional
Remedial Action Other
Type of Report Initial,Followup
Report Date 02/02/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberTABLETOP
Device Catalogue Number8065751150
Other Device ID Number4.00.168
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 11/02/2016
Initial Date FDA Received11/28/2016
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received02/03/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured06/20/2016
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Patient Outcome(s) Other;
-
-